Skip to main content

Inspire patent information

INSPIRE® sleep apnea treatment system and/or the use thereof in a method may be covered by one or more U.S. and/or foreign patents, including: US 6,021,352, US 8,340,785, US 9,452,293, US 9,227,053, US 9,839,786, US D801,538, EP 2310082, EP 2310083, EP 2310084, and EP 2323730. Other U.S. and foreign patent applications are pending. This page is intended to serve as notice under 35 U.S.C. § 287(a).

1 ADHERE Registry: Data on file
2 Woodson BT, Strohl KP, Soose RJ, et al. Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes. Otolaryngol Head Neck Surgery 2018; 159(1):194-202
3 Suurna MV, Steffen A, Boon M, et al. Impact of Body Mass Index and Discomfort on Upper Airway Stimulation: ADHERE Registry 2020 Update. Laryngoscope 2021; 131(11): 2616-2624
4 Heiser et al., ERJ 2019.
5 Source: Peppard, P.E., Young, T., Barnet, J.H., Palta, M., Hagen, E. W., Hla, K. M., (2013). Increased Prevalence of Sleep-Disordered Breathing in Adults, American Journal of Epidemiology, 1014